TD
Thomas E Daley
Chief Business Officer

Thomas E Daley insider trades: Raptor Pharmaceutical (RPTP) stock sales

Chief Business Officer, Raptor Pharmaceutical Last trade Jun 18, 2015 26 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
11
Open-market trades
since 2012
2
Companies
last trade 2015

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Thomas reports to the SEC

Open-market buys and sales

11 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jun 18, 2015RPTP↓ Sell$525K
May 20, 2015RPTP↓ Sell$120K
Jan 9, 2014RPTP↓ Sell$213K
Nov 11, 2013RPTP↓ Sell$192K
Sep 9, 2013RPTP↓ Sell$357K
Dec 17, 2012RPTP↓ Sell$18K
Oct 15, 2012RPTP↓ Sell$17K
Aug 27, 2012RPTP↓ Sell$17K
Jun 15, 2012RPTP↓ Sell$19K
Apr 16, 2012RPTP↓ Sell$20K
Feb 15, 2012RPTP↓ Sell$26K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Thomas E Daley's insider trades

Thomas E Daley is Chief Business Officer at Raptor Pharmaceutical (RPTP). Since Feb 15, 2012, Thomas has reported no open-market purchases and 11 sales worth $1.5M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (10 filings), other transactions (4 filings), option exercises (3 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RPTP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.